Multiple sclerosis in 2021: progress against progression.
Lancet Neurol. 2022 Jan;21(1):12-13. doi: 10.1016/S1474-4422(21)00417-8.
Lancet Neurol. 2022.
PMID: 34942123
No abstract available.